KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Net Cash Flow (2016 - 2025)

CareDx (CDNA) has disclosed Net Cash Flow for 13 consecutive years, with -$26.0 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow fell 237.81% to -$26.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$49.2 million through Dec 2025, down 253.96% year-over-year, with the annual reading at -$49.2 million for FY2025, 253.96% down from the prior year.
  • Net Cash Flow hit -$26.0 million in Q4 2025 for CareDx, down from $23.2 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $174.7 million in Q1 2021 to a low of -$176.6 million in Q1 2022.
  • Historically, Net Cash Flow has averaged -$3.5 million across 5 years, with a median of $1.0 million in 2024.
  • Biggest YoY gain for Net Cash Flow was 5127.92% in 2025; the steepest drop was 929.72% in 2025.
  • Year by year, Net Cash Flow stood at -$4.4 million in 2021, then soared by 263.78% to $7.3 million in 2022, then dropped by 16.18% to $6.1 million in 2023, then soared by 208.97% to $18.9 million in 2024, then tumbled by 237.81% to -$26.0 million in 2025.
  • Business Quant data shows Net Cash Flow for CDNA at -$26.0 million in Q4 2025, $23.2 million in Q3 2025, and -$20.5 million in Q2 2025.